About Liberation Bioindustries
Liberation Bioindustries is a private company based in New York, New York, incorporated in 2022 in Delaware. It has reported $121,247,331 raised in three offerings on Form D since October 2022. Its chief executive is Mark Warner.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 24, 2025 | Dec 10, 2025 | $60,164,351of $101.6M target | 7 | $8.5M | EquityRule 506(b) | Form D ↗ |
| Jan 28, 2025 | Feb 10, 2025 | $51,982,971fully sold | 6 | $8.6M | DebtRule 506(b) | Form D ↗ |
| Oct 19, 2022 | Oct 28, 2022 | $9,100,009of $20.0M target | 4 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $121,247,331 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Liberation Bioindustries's Form D filed Dec 10, 2025.
PB
Philip Boigner
Director
JM
James Mellon
Director
EB
Etan Bendheim
Executive officer
MW
Mark Warner
CEO and director
BK
Babar Khan
Director
SF
Steven Finn
Director
Earlier filings also listed Anthony Chow (director, last listed Oct 2022).